Cell Impact AB(SE:CI)
kr 0.02+0.00 (+12.50%)
SE:CI
Cell Impact AB financials statements
kr 0.02
At close:+0.00 (+12.50%)
Want to see SE:CI full AI Analyst Report?
Cell Impact AB (CI) Ratios
2 Followers
Cell Impact AB Ratios
SE:CI's free cash flow for Q3 2026 was kr-15.77M. For the 2026 fiscal year, SE:CI's free cash flow was increased by kr0.00 and operating cash flow was kr-15.77M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.02 | 3.03 | 3.58 | 5.43 | 1.60 |
| Quick Ratio | 0.61 | 1.33 | 2.26 | 4.36 | 1.32 |
| Cash Ratio | 0.31 | 0.85 | 2.07 | 3.76 | 0.36 |
| Solvency Ratio | -1.40 | -1.64 | -1.28 | -1.14 | -0.74 |
| Operating Cash Flow Ratio | -1.28 | -2.58 | -2.10 | -2.42 | -1.08 |
| Short-Term Operating Cash Flow Coverage | -3.06 | -7.58 | -12.29 | -12.90 | -120.55 |
| Net Current Asset Value | kr 29.13M | kr 30.88M | kr 94.16M | kr 160.67M | kr 31.64M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.12 | 0.11 | 0.11 | 0.08 |
| Debt-to-Equity Ratio | 0.27 | 0.14 | 0.14 | 0.14 | 0.14 |
| Debt-to-Capital Ratio | 0.21 | 0.12 | 0.12 | 0.12 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.03 | 0.05 | 0.07 | 0.03 |
| Financial Leverage Ratio | 1.35 | 1.19 | 1.26 | 1.24 | 1.67 |
| Debt Service Coverage Ratio | -2.91 | -6.18 | -8.68 | -8.85 | -28.68 |
| Interest Coverage Ratio | -30.73 | -38.62 | -39.13 | -67.27 | -46.18 |
| Debt to Market Cap | 0.67 | 0.02 | 0.10 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.18 | 0.05 | 0.42 | 0.19 | 0.11 |
| Net Debt to EBITDA | -0.39 | -0.16 | 0.58 | 1.39 | 0.13 |
| Profitability Margins | |||||
| Gross Profit Margin | -2179.98% | 14.51% | 53.86% | 48.09% | 48.88% |
| EBIT Margin | -2296.48% | -261.98% | -250.33% | -133.58% | -109.38% |
| EBITDA Margin | -987.90% | -178.21% | -206.77% | -112.25% | -96.48% |
| Operating Profit Margin | -2242.94% | -265.29% | -252.83% | -134.70% | -109.38% |
| Pretax Profit Margin | -2369.46% | -268.85% | -256.80% | -135.58% | -111.75% |
| Net Profit Margin | -2369.55% | -269.08% | -256.88% | -135.68% | -111.92% |
| Continuous Operations Profit Margin | -2369.55% | -269.08% | -256.88% | -135.67% | -111.92% |
| Net Income Per EBT | 100.00% | 100.08% | 100.03% | 100.07% | 100.15% |
| EBT Per EBIT | 105.64% | 101.34% | 101.57% | 100.66% | 102.17% |
| Return on Assets (ROA) | -80.79% | -38.44% | -31.79% | -25.96% | -33.45% |
| Return on Equity (ROE) | -109.05% | -45.84% | -40.02% | -32.13% | -55.99% |
| Return on Capital Employed (ROCE) | -97.60% | -41.75% | -35.80% | -28.93% | -49.17% |
| Return on Invested Capital (ROIC) | -84.61% | -39.61% | -34.52% | -28.04% | -48.13% |
| Return on Tangible Assets | -85.54% | -39.74% | -32.64% | -26.58% | -34.23% |
| Earnings Yield | -406.57% | -11.36% | -49.22% | -1.26% | -0.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.53 | 4.27 | 82.77 | 4.06 | 2.78 |
| Payables Turnover | 29.05 | 20.12 | 2.35 | 2.99 | 2.41 |
| Inventory Turnover | 2.54 | 0.78 | 0.34 | 0.85 | 1.66 |
| Fixed Asset Turnover | 0.07 | 0.21 | 0.24 | 0.50 | 0.68 |
| Asset Turnover | 0.03 | 0.14 | 0.12 | 0.19 | 0.30 |
| Working Capital Turnover Ratio | 0.13 | 0.43 | 0.30 | 0.64 | 0.70 |
| Cash Conversion Cycle | 824.96 | 537.42 | 918.27 | 396.04 | 199.59 |
| Days of Sales Outstanding | 693.76 | 85.48 | 4.41 | 89.85 | 131.31 |
| Days of Inventory Outstanding | 143.77 | 470.09 | 1069.31 | 428.25 | 219.43 |
| Days of Payables Outstanding | 12.57 | 18.14 | 155.45 | 122.06 | 151.15 |
| Operating Cycle | 837.53 | 555.57 | 1073.72 | 518.10 | 350.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.22 | -0.10 | -0.92 | -0.44 | -0.46 |
| Free Cash Flow Per Share | -0.23 | -0.12 | -1.39 | -0.73 | -0.75 |
| Dividend Paid and CapEx Coverage Ratio | -23.55 | -4.31 | -1.89 | -1.55 | -1.58 |
| Capital Expenditure Coverage Ratio | -23.55 | -4.31 | -1.89 | -1.55 | -1.58 |
| Operating Cash Flow Coverage Ratio | -1.39 | -2.01 | -2.36 | -2.37 | -4.41 |
| Operating Cash Flow to Sales Ratio | -8.14 | -1.67 | -2.14 | -1.38 | -1.21 |
| Free Cash Flow Yield | -145.67% | -8.67% | -61.92% | -2.10% | -0.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.25 | -8.80 | -2.03 | -79.57 | -197.97 |
| Price-to-Sales (P/S) Ratio | 5.83 | 23.68 | 5.22 | 107.96 | 221.57 |
| Price-to-Book (P/B) Ratio | 0.27 | 4.03 | 0.81 | 25.57 | 110.84 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.69 | -11.53 | -1.61 | -47.57 | -112.61 |
| Price-to-Operating Cash Flow Ratio | -0.72 | -14.20 | -2.44 | -78.28 | -183.66 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.10 | -0.01 | -34.22 | -2.75 |
| Enterprise Value Multiple | -0.98 | -13.45 | -1.94 | -94.79 | -229.52 |
| Enterprise Value | 54.14M | 894.50M | 189.53M | 8.17B | 15.80B |
| EV to EBITDA | -0.98 | -13.45 | -1.94 | -94.79 | -229.52 |
| EV to Sales | 9.72 | 23.97 | 4.01 | 106.40 | 221.44 |
| EV to Free Cash Flow | -1.14 | -11.67 | -1.24 | -46.88 | -112.54 |
| EV to Operating Cash Flow | -1.19 | -14.37 | -1.88 | -77.15 | -183.55 |
| Tangible Book Value Per Share | 0.56 | 0.34 | 2.68 | 1.32 | 0.73 |
| Shareholders’ Equity Per Share | 0.60 | 0.35 | 2.77 | 1.36 | 0.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.03 | 0.06 | 0.43 | 0.32 | 0.38 |
| Net Income Per Share | -0.65 | -0.16 | -1.11 | -0.44 | -0.43 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.03 | 1.03 | 1.03 | 1.01 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.08 | 0.06 | 0.02 | 0.01 |
| SG&A to Revenue | 0.00 | 1.67 | 0.00 | 0.56 | 0.56 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.34 | 0.62 | 0.83 | 1.02 | 1.10 |
Currency in SEK

